Equity
€405,245 ▲ 110%
Equity rose in 2025 from €192,873 to €405,245.
SCANRE
Lifetime
2 annual accounts with figures on one time axispeak €281,557 (2025)
€281,557▲ 11.0%
peak €212,372 (2025)
€212,372▲ 11.8%
peak €405,245 (2025)
€405,245▲ 110%
€130,889▲ 93.1%
Board1 name since 2024
1 director
Documentsfilings and deeds
05-06-202656 days before the deadline
2025micro format
Equity from €192,873 to €405,245Debts from €67,779 to €130,889Cash from €125,156 to €419,466
Key points
from the 2025 annual accountsTurnover
≈ €430,000 estimated
The micro format states no turnover.
Position in the sector
€212,372
Higher net result than 89% of companies in human health. Sector median €59,542 · 21,298 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,127 companies had the same profile as SCANRE has now. Each dot stands for 8 companies, two years later.
97.2%
were still trading
1.9%
stopped another way
0.8%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,127 companies, not a prediction for SCANRE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1012441062
Incorporation
Founding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 16-08-2024 · Gazette deed
First establishment
Gierledreef 32, Turnhout
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SCANRE Turnhout | €536,134 | €281,557 | 75.6% | - |
| Dr Adeline Higuet Uccle | €605,328 | €288,320 | 31.2% | - |
| OOGCENTRUM EOS Mol | €662,396 | €291,676 | 10.7% | - |
| Dokter Vinke Geel | €567,057 | €252,013 | 59.9% | - |
| o.lives Edegem | €541,460 | €246,318 | 75.7% | - |
| OculoMax Bonheiden | €466,509 | €281,811 | 84.3% | - |
| Dr. Noémie Ampe Antwerp | €563,804 | €260,406 | 80.0% | - |
These companies have the same main activity as SCANRE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €467,000 and €662,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 13-08-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.362.693.8312300 Turnhout, since 13-08-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 20-03-2026
Annual accounts 2025
- €536,134▲ 106%
- Filing
- Filed on 05-06-2026, 56 days before the end of the filing period
Insights on SCANRE
SCANRE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €405,245 and a net result of €212,372.
Its solvency ranks better than 64% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about SCANRE
- What is the company number of SCANRE?
- The company number of SCANRE is 1012.441.062. The VAT number is the same number with BE in front: BE 1012.441.062.
- Where is SCANRE based?
- The registered office is at Gierledreef 32, 2300 Turnhout.Company details
- What does SCANRE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of SCANRE?
- SCANRE is a private limited company (BV).
- When was SCANRE founded?
- SCANRE was founded on 13-08-2024.
- Is SCANRE still active?
- Yes, SCANRE is an active enterprise in the KBO register.
- What is the turnover of SCANRE?
- The turnover in financial year 2025 is ≈ €430,000. This figure is estimated from the gross margin of €281,557 and 30 comparable companies (NACE 86220). It probably lies between €380,000 and €590,000.Financials
- Is SCANRE profitable?
- In financial year 2025, SCANRE made a profit of €212,372.
- Where can I find the annual accounts of SCANRE?
- SCANRE filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of SCANRE due?
- SCANRE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.